| Drug Name: | Bilirubin (635-65-4) |
|---|---|
| PubChem ID: | 5280352 |
| SMILES: | CC1=C(NC(=C1CCC(=O)O)CC2=C(C(=C(N2)/C=C3/C(=C(C(=O)N3)C)C=C)C)CCC(=O)O)/C=C4/C(=C(C(=O)N4)C=C)C |
| InchiKey: | BPYKTIZUTYGOLE-IFADSCNNSA-N |
| Therapeutic Category: | Antioxidants, Protective Agents |
| Molecular Weight (dalton) | : | 584.673 |
| LogP | : | 4.53124 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 6 |
| Total Polar Surface Area | : | 164.38 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category